Advertisement
Screener

SAB BIOTHERAPEUTICS, INC. (SABS) ROA

SAB BIOTHERAPEUTICS, INC. (SABS) ROA

  • 2026-06-30: ROA -5.36%.
  • 2026-03-31: ROA -0.16%.
  • 2025-12-31: ROA 7.68%.
  • 2025-09-30: ROA 10.22%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-5.36%
2026-03-31-0.16%
2025-12-317.68%
2025-09-3010.22%
2025-06-30-122.99%
2025-03-31-89.92%
2024-12-31-77.17%
2024-09-30-84.70%
2024-06-30-65.15%
2024-03-31-55.86%
2023-12-31-50.27%
2023-09-30-96.03%
2023-06-30-82.35%
2023-03-31-63.46%
2022-12-31-36.82%
2022-09-30-42.69%
2022-06-30-32.66%
2022-03-31-25.65%
2021-12-31-21.13%

Annual ROA

DateROA
2025-12-317.68%
2024-12-31-77.17%
2023-12-31-50.27%
2022-12-31-36.82%
2021-12-31-21.13%
2020-12-3135.58%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Ocugen, Inc. (OCGN)United States$0.343B-6.34
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05